Concepedia

William David

WD

11

Publications

1.9K

Citations

11

H-Index

2006

Active since

Affiliations

Massachusetts General Hospital(Current)

Harvard University

Pfizer (United States)

Penn State Milton S. Hershey Medical Center

University of North Carolina at Chapel Hill

William David is an author at Massachusetts General Hospital specializing in medicine, pharmacology, and virology.

Top concepts

Publications per year

2006–2020

11

Publications

11

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

, , +3

An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study

Timothy M. Miller, Alan Pestronk, William David et al. · The Lancet Neurology · 2013 · 603 citations · Full text

A randomized controlled trial of methotrexate for patients with generalized myasthenia gravis

Mamatha Pasnoor, Jianghua He, Laura Herbelin et al. · Neurology · 2016 · 129 citations · Full text

The ALSSQOL

Zachary Simmons, S. H. Felgoise, Barbara A. Bremer et al. · Neurology · 2006 · 127 citations

Randomized trial of <scp>l</scp> -serine in patients with hereditary sensory and autonomic neuropathy type 1

Vera Fridman, Saranya Suriyanarayanan, Péter Novák et al. · Neurology · 2019 · 111 citations · Full text

Rows per page

1–5 of 11